Free Trial
→ Massive shakeup in defense contracting (From DTI) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 8 of 15

Slide 8
Back to 7
Continue to 9
 
Back to 7
Continue to 9
 

Revolution Medicines (NASDAQ:RVMD)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
12 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$61.00 (4.0% Upside)

About Revolution Medicines

Revolution Medicines logoRevolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/7/2024HC WainwrightBoost Price TargetBuy ➝ Buy$62.00 ➝ $64.00
11/7/2024Needham & Company LLCBoost Price TargetBuy ➝ Buy$61.00 ➝ $68.00
11/7/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$54.00 ➝ $63.00
11/7/2024Piper SandlerBoost Price TargetOverweight ➝ Overweight$57.00 ➝ $70.00
10/28/2024GuggenheimBoost Price TargetBuy ➝ Buy$72.00 ➝ $82.00
10/28/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$55.00 ➝ $60.00
10/24/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$61.00 ➝ $61.00
10/7/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$61.00 ➝ $61.00
9/27/2024BarclaysBoost Price TargetOverweight ➝ Overweight$54.00 ➝ $60.00
8/12/2024HC WainwrightReiterated RatingBuy ➝ Buy$56.00 ➝ $56.00
Slide 8
Back to 7
Continue to 9
 

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

More From MarketBeat
Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
7 Dividend Stocks to Buy Under $20
On September 18, 2024, the Federal Reserve dropped its federal funds rate by 50 basis points (0.5%). Furthermo...
MarketBeat
⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
Behind the Markets | Sponsored
13 Stocks With Strong Institutional Buying
Hedge funds, university endowments, pension funds, and sovereign wealth funds have been pouring money into an ...
MarketBeat
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
7 Artificial Intelligence Stocks That Are Still Long-Term Winners
It's hard to believe that two years ago, many of us had never heard of ChatGPT. But for the last 18 months, in...
MarketBeat